Home/Filings/4/0001179110-17-009094
4//SEC Filing

IMMUNOGEN INC 4

Accession 0001179110-17-009094

CIK 0000855654operating

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 10:00 AM ET

Size

7.8 KB

Accession

0001179110-17-009094

Insider Transaction Report

Form 4
Period: 2017-06-13
Transactions
  • Award

    Stock option (right to buy)

    2017-06-13$4.64/sh+10,000$46,40010,000 total
    Exercise: $4.64From: 2017-09-01Exp: 2027-06-13Common Stock (10,000 underlying)
  • Award

    Deferred Share Unit

    2017-06-13+3,00089,845 total
    Exercise: $0.00From: 2017-09-01Common Stock (3,000 underlying)
Footnotes (4)
  • [F1]The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis.
  • [F2]The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors.
  • [F3]The deferred share units vest quarterly on 9/1/17, 12/1/17, 3/1/18 and 6/1/18, contingent upon the individual remaining a director as of each vesting date.
  • [F4]Exercisable as to 2,500 shares on 9/1/17, 12/1/17, 3/1/18 and 6/1/18, contingent upon the individual remaining a director as of each vesting date.

Issuer

IMMUNOGEN INC

CIK 0000855654

Entity typeoperating
IncorporatedMA

Related Parties

1
  • filerCIK 0000855654

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 10:00 AM ET
Size
7.8 KB